CureSearch Research Programs: Request for Applications
For more than 30 years, CureSearch has been a driving force in pediatric cancer research. Recognizing a broken system, growing obstacles, and unmet needs in drug development, we’ve launched an innovative and unique strategy to address the urgent, critical need for new childhood cancer treatments. Our success is measured by the rate of a funded project’s progress toward the clinic and marketplace where new treatments can directly impact patients, not by total dollars spent or by publishing in academic journals. We’re focused on results, holding our researchers accountable to rigorous six-month milestones; continued funding is dependent on achieving agreed upon goals
Funding Opportunity Announcement
The application window to submit Letters of Intent (LOIs) will open October 5, 2020. CureSearch will fund high potential projects that address areas of high, unmet needs in pediatric cancer, driving the development of better, less-toxic children’s cancer treatments.
|Request for Applications Opens||October 5, 2020|
|Letter of Intent Deadline||November 30, 2020|
|LOI Notification/Full Applications Invited||February 8, 2021|
|Full Applications Due||April 5, 2021|
|Earliest Award Notification*||October 4, 2021|
|Program||Opportunity Summary||RFA||Submission Site|
|Young Investigator||An opportunity for funding up to $75,000 per year for up to three years. Provides seed support for bright researchers, early in their careers, pursuing exciting and novel research in pediatric oncology.||LOI application window opens October 5, 2020. Young Investigator Submission Site|
|Acceleration Initiative||An opportunity for funding in the range of $500,000 – $1.5 million. The Acceleration Initiative funds scientific or technological innovation with the highest likelihood of identifying a breakthrough in childhood cancer treatments and becoming an impactful therapeutic option for children in the near term.||LOI application window opens October 5, 2020 Acceleration Initiative Submission Site|
Funding will be provided for up to three years, contingent on demonstration of satisfactory and timely completion of milestones.
Click here to add yourself to our mailing list and be the first to know about new RFAs.
Please email Caitlyn Barrett, PhD, National Director of Research and Programs, with any questions or comments.